Capital Flow Monitor · Sponsors · CIK 2158173
Immuno Cancer Biotherapeutics, Inc.
48351 277TH ST, CANTON, SD, 57013-5507 · 6053107663
Biotechnology · Corporation· inc. DELAWARE true 2024
Fit score
—
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | D | 506(b) | — | $75K | — | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- James Robl — Executive Officer / Director, CANTON, SD
-
Stephen Collins — Director, LAKE FOREST, IL
11 other raises
- PGIM Lending Fund (Foxtrot) (Rated Feeder Fund), L.P. $0 of —
- AtomBeam Technologies Inc. $0 of $10.0M · 0.0%
- PGIM Senior Loan Opportunities Management Feeder Fund II, L.P. $0 of —
- PGIM SENIOR LOAN OPPORTUNITIES MANAGEMENT FUND II, L.P. $0 of —
- PGIM Senior Loan Opportunities II JPY Feeder Fund, L.P. $124.2M of —
- PGIM Senior Loan Opportunities (Unlevered) II, L.P. $1.78B of —
- PGIM Senior Loan Opportunities (Rated Feeder Fund) II, L.P. $1.78B of —
- PGIM Senior Loan Opportunities (Parallel Fund) II, L.P. $236.2M of —
- PGIM Senior Loan Opportunities (Offshore Rated Feeder Fund) II, L.P. $0 of —
- PGIM Senior Loan Opportunities (Levered) II, L.P. $90.0M of —
- PGIM Senior Loan Opportunities (Levered Rated Feeder Fund) II, L.P. $0 of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.